Brivaracetam, plasma

Alphabetical Test listing

Brivaracetam, plasma-994

  
Brivaracetam, plasma
  
994
  
LAB994
  
MSO
  
Briviact
  

Therapeutic drug monitoring (TDM)

  
EDTA plasma
  
  
1.0 mL
  
0.2 mL
  
  1. Spin
  2. Transfer plasma to a Screw cap transfer via/tube (Mayo T465)
  
  

 

 

  

Refrigerated (preferred) - 30 days

Ambient - 30 days

Frozen - 90 days

  
  • Serum
  • Plasma gel tubes
  
NMS (0718SP) via Mayo Clinic Laboratories (FBRIV): R-NX
  
Daily
  
8 days
  

High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)

  

Report limit 0.1 µg/mL

The recommended steady-state Brivaracetam plasma concentration for seizure control is 0.2 to 2.0 mcg/mL.

 

  
80299
  
Yes
  
  
12/14/2018
  
09/20/2021
  
09/20/2021